Thursday, December 03, 2020 9:33:42 AM
Indeed, I was multitasking and juggling a dozen things, and still fully awake. Good catch. You are right, it was the wrong ticker.
RVVTF could be a monster ride with such tiny market cap, which is likely because it is not a US Exchange listed stock.
FDA Covid19 clinical trial wake up news will send it to dollar fast.
Very low risk very high reward bet here.
RVVTF could be a monster ride with such tiny market cap, which is likely because it is not a US Exchange listed stock.
FDA Covid19 clinical trial wake up news will send it to dollar fast.
Very low risk very high reward bet here.
All of my posts are strictly opinions and should not be considered to be facts, or investment advise. They are for entertainment purposes only.
Recent RVVTF News
- Revive Therapeutics Strengthens Bucillamine IP Portfolio with North American Patent Filings for Nerve Agent Exposure and Granted Canadian Patent for Infectious Diseases • ACCESS Newswire • 03/11/2026 11:30:00 AM
- Revive Therapeutics Provides Update of Key Nerve Agent Countermeasure Study • GlobeNewswire Inc. • 12/15/2025 12:30:00 PM
- Revive Therapeutics Provides Update of Key Nerve Agent Countermeasure Study • GlobeNewswire Inc. • 11/21/2025 05:07:49 PM
- Revive Therapeutics Announces Closing of Second Tranche of Private Placement • GlobeNewswire Inc. • 09/19/2025 09:00:28 PM
